An Cheng, PhD

Title(s)Postdoctoral Scholar, Ophthalmology
SchoolSchool of Medicine
Address1550 Fourth Street, #445
San Francisco CA 94158
ORCID ORCID Icon0000-0002-7816-203X Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Tohoku University, Sendai, JapanPh.D.03/2022Neuropharmacology
    China Pharmaceutical University, Nanjing, ChinaB.S.06/2016Pharmaceutical Science
    Collapse Awards and Honors
    Tohoku University2022Tohoku University President’s Award
    Tohoku University2021Tohoku University Professor Fujino Incentive Award
    The Uehara Memorial Foundation2020  - 2021The Uehara Memorial Foundation Fellowship

    Collapse Overview 
    Collapse Overview
    As a Postdoctoral Scholar in the Ophthalmology department at UCSF, my research interests revolve around neurodegeneration and aging. Through my authored research publications, I have contributed to the understanding of fatty acid-binding proteins (FABPs) and their involvement in neurodegenerative diseases such as Parkinson's disease. My work includes exploring novel therapeutic approaches and inhibitors to protect against memory loss and mitochondrial damage induced by neurodegenerative processes. I am honored to have received prestigious awards and fellowships, including the Tohoku University President's Award and The Uehara Memorial Foundation Fellowship. I hold a Ph.D. in Neuropharmacology from Tohoku University, Sendai, Japan, and a B.S. in Pharmaceutical Science from China Pharmaceutical University, Nanjing, China.

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Feasibility and considerations of epsin2 as a candidate target for multiple system atrophy treatment. Expert Opin Ther Targets. 2023 Jul-Dec; 27(11):1031-1034. Cheng A, Cai B, Fukunaga K, Sasaki T, Lakkaraju A. PMID: 37902421.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Editorial: Myelin in white mater function and related diseases. Front Mol Neurosci. 2023; 16:1284273. Tian Z, Cheng A. PMID: 37771557; PMCID: PMC10523341.
      View in: PubMed   Mentions:
    3. Pharmacological inhibition of FABP7 by MF 6 counteracts cerebellum dysfunction in an experimental multiple system atrophy mouse model. Acta Pharmacol Sin. 2024 Jan; 45(1):66-75. Cheng A, Jia W, Finkelstein DI, Stefanova N, Wang H, Sasaki T, Kawahata I, Fukunaga K. PMID: 37605049; PMCID: PMC10770047.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    4. Epsin2, a novel target for multiple system atrophy therapy via α-synuclein/FABP7 propagation. Brain. 2023 08 01; 146(8):3172-3180. Cheng A, Kawahata I, Wang Y, Jia W, Wang H, Sekimori T, Chen Y, Suzuki H, Takeda A, Stefanova N, Finkelstein DI, Ma W, Chen M, Sasaki T, Fukunaga K. PMID: 37082980.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    5. Amelioration of Nicotine-Induced Conditioned Place Preference Behaviors in Mice by an FABP3 Inhibitor. Int J Mol Sci. 2023 Apr 02; 24(7). Jia W, Kawahata I, Cheng A, Sasaki T, Sasaoka T, Fukunaga K. PMID: 37047614; PMCID: PMC10095245.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    6. Novel FABP3 ligand, HY-11-9, ameliorates neuropathological deficits in MPTP-induced Parkinsonism in mice. J Pharmacol Sci. 2023 May; 152(1):30-38. Wang H, Fukunaga K, Cheng A, Wang Y, Arimura N, Yoshino H, Sasaki T, Kawahata I. PMID: 37059489.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    7. α-Synuclein decoy peptide protects mice against α-synuclein-induced memory loss. CNS Neurosci Ther. 2023 06; 29(6):1547-1560. Guo Q, Kawahata I, Jia W, Wang H, Cheng A, Yabuki Y, Shioda N, Fukunaga K. PMID: 36786129; PMCID: PMC10173724.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    8. Fatty acid-binding proteins 3 and 5 are involved in the initiation of mitochondrial damage in ischemic neurons. Redox Biol. 2023 02; 59:102547. Guo Q, Kawahata I, Cheng A, Wang H, Jia W, Yoshino H, Fukunaga K. PMID: 36481733; PMCID: PMC9727700.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    9. Fatty Acid-Binding Proteins: Their Roles in Ischemic Stroke and Potential as Drug Targets. Int J Mol Sci. 2022 Aug 25; 23(17). Guo Q, Kawahata I, Cheng A, Jia W, Wang H, Fukunaga K. PMID: 36077044; PMCID: PMC9455833.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    10. [Role of fatty acid-binding protein 7 and novel therapeutic approach in synucleinopathies]. Nihon Yakurigaku Zasshi. 2022; 157(6):396-400. Cheng A, Fukunaga K. PMID: 36328545.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models. EBioMedicine. 2021 Oct; 72:103582. Cheng A, Jia W, Kawahata I, Fukunaga K. PMID: 34624687; PMCID: PMC8502714.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    12. Hydroxyl-Directed Ruthenium-Catalyzed peri-Selective C-H Acylmethylation and Annulation of Naphthols with Sulfoxonium Ylides. Org Lett. 2021 Aug 20; 23(16):6200-6205. Ma W, Tan Y, Wang Y, Li Z, Li Z, Gu L, Mei R, Cheng A. PMID: 34339192.
      View in: PubMed   Mentions: 1     Fields:    
    13. Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy. Biomedicines. 2021 May 17; 9(5). Cheng A, Jia W, Kawahata I, Fukunaga K. PMID: 34067791; PMCID: PMC8156290.
      View in: PubMed   Mentions: 2  
    14. Fatty acid-binding protein 7 triggers α-synuclein oligomerization in glial cells and oligodendrocytes associated with oxidative stress. Acta Pharmacol Sin. 2022 Mar; 43(3):552-562. Cheng A, Wang YF, Shinoda Y, Kawahata I, Yamamoto T, Jia WB, Yamamoto H, Mizobata T, Kawata Y, Fukunaga K. PMID: 33935286; PMCID: PMC8888578.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    15. The Role of CaMKII and ERK Signaling in Addiction. Int J Mol Sci. 2021 Mar 20; 22(6). Jia W, Kawahata I, Cheng A, Fukunaga K. PMID: 33804804; PMCID: PMC8004038.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    16. Ligand Bound Fatty Acid Binding Protein 7 (FABP7) Drives Melanoma Cell Proliferation Via Modulation of Wnt/β-Catenin Signaling. Pharm Res. 2021 Mar; 38(3):479-490. Umaru BA, Kagawa Y, Shil SK, Arakawa N, Pan Y, Miyazaki H, Kobayashi S, Yang S, Cheng A, Wang Y, Shinoda Y, Kiniwa Y, Okuyama R, Fukunaga K, Owada Y. PMID: 33646504.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    17. Epidermal Fatty Acid-Binding Protein 5 (FABP5) Involvement in Alpha-Synuclein-Induced Mitochondrial Injury under Oxidative Stress. Biomedicines. 2021 Jan 22; 9(2). Wang Y, Shinoda Y, Cheng A, Kawahata I, Fukunaga K. PMID: 33499263; PMCID: PMC7911662.
      View in: PubMed   Mentions: 7  
    18. Single Administration of the T-Type Calcium Channel Enhancer SAK3 Reduces Oxidative Stress and Improves Cognition in Olfactory Bulbectomized Mice. Int J Mol Sci. 2021 Jan 13; 22(2). Yuan D, Cheng A, Kawahata I, Izumi H, Xu J, Fukunaga K. PMID: 33451040; PMCID: PMC7828528.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    19. Impaired Acquisition of Nicotine-Induced Conditioned Place Preference in Fatty Acid-Binding Protein 3 Null Mice. Mol Neurobiol. 2021 May; 58(5):2030-2045. Jia W, Wilar G, Kawahata I, Cheng A, Fukunaga K. PMID: 33411237.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    20. Fatty Acid Binding Protein 5 Mediates Cell Death by Psychosine Exposure through Mitochondrial Macropores Formation in Oligodendrocytes. Biomedicines. 2020 Dec 20; 8(12). Cheng A, Kawahata I, Fukunaga K. PMID: 33419250; PMCID: PMC7766880.
      View in: PubMed   Mentions: 9  
    21. Inhibition of MPTP-induced α-synuclein oligomerization by fatty acid-binding protein 3 ligand in MPTP-treated mice. Neuropharmacology. 2019 05 15; 150:164-174. Matsuo K, Cheng A, Yabuki Y, Takahata I, Miyachi H, Fukunaga K. PMID: 30930168.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    22. Development of FABP3 ligands that inhibit arachidonic acid-induced α-synuclein oligomerization. Brain Res. 2019 03 15; 1707:190-197. Cheng A, Shinoda Y, Yamamoto T, Miyachi H, Fukunaga K. PMID: 30496735.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    An's Networks
    Concepts (91)
    Derived automatically from this person's publications.
    Co-Authors (1)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department